The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE
Open accessAbstract
Objective: To test the hypothesis that the performance of first‐trimester screening for pre‐eclampsia (PE) by a method that uses Bayes' theorem to combine maternal factors with biomarkers is superior to that defined by current National Institute for Health and Care Excellence (NICE) guidelines. Methods: This was a prospective multicenter study (screening program for pre‐eclampsia (SPREE)) in seven National Health Service maternity hospitals in England, of women recruited between April and December 2016. Singleton pregnancies at 11–13 weeks' gestation had recording of maternal characteristics and medical history and measurements of mean arterial pressure (MAP), uterine artery pulsatility index (UtA‐PI), serum placental growth factor (PlGF) and serum pregnancy‐associated plasma protein‐A (PAPP‐A). The performance of screening for PE by the Bayes' theorem‐based method was compared with that of the NICE method. Primary comparison was detection rate (DR) using NICE method vs mini‐combined test (maternal factors, MAP and PAPP‐A) in the prediction of PE at any gestational age (all‐PE) for the same screen‐positive rate determined by the NICE method. Key secondary comparisons were DR of screening recommended by the NICE guidelines vs three Bayes' theorem‐based methods (maternal factors, MAP and PAPP‐A; maternal factors, MAP and PlGF; and maternal factors, MAP, UtA‐PI and PlGF) in the prediction of preterm PE, defined as that requiring delivery < 37 weeks. Results: All‐PE developed in 473 (2.8%) of the 16 747 pregnancies and preterm PE developed in 142 (0.8%). The screen‐positive rate by the NICE method was 10.3% and the DR for all‐PE was 30.4% and for preterm PE it was 40.8%. Compliance with the NICE recommendation that women at high risk for PE should be treated with aspirin from the first trimester to the end of pregnancy was only 23%. The DR of the mini‐combined test for all‐PE was 42.5%, which was superior to that of the NICE method by 12.1% (95% CI, 7.9–16.2%). In screening for preterm PE by a combination of maternal factors, MAP and PlGF, the DR was 69.0%, which was superior to that of the NICE method by 28.2% (95% CI, 19.4–37.0%) and with the addition of UtA‐PI the DR was 82.4%, which was higher than that of the NICE method by 41.6% (95% CI, 33.2–49.9%). Conclusions: The performance of screening for PE as currently recommended by NICE guidelines is poor and compliance with these guidelines is low. The performance of screening is substantially improved by a method combining maternal factors with biomarkers. © 2018 Crown copyright. Ultrasound in Obstetrics & Gynecology © 2018 ISUOG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility
Lunn, D. J., Thomas, A., Best, N., & Spiegelhalter, D. (2000) · Statistics and Computing · doi:10.1023/a:1008929526011 · Cited by 5,368
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287
Self-citationBrown, M. A., Lindheimer, M. D., Swiet, M. D., Assche, A. V., & Moutquin, J.-M. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
Markov Chain Monte Carlo in Practice
Gasparini, M. (1997) · Technometrics · doi:10.1080/00401706.1997.10485132 · Cited by 1,879
A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS
Robinson, H. P., & Fleming, J. E. E. (1975) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1975.tb00710.x · Cited by 1,413
Irgens, H. U., Roberts, J. M., Reisæter, L., Irgens, L. M., & Lie, R. T. (2001) · BMJ · doi:10.1136/bmj.323.7323.1213 · Cited by 1,040 · cited 1×
“The data, blinded to outcome, were then provided to the study statistician who (1) defined the screen-positive group according to NICE criteria, (2) computed risks for all-PE and preterm PE for the prespecified combinations of biomarkers using the Bayes’ theorem-based method11,12, (3) identified the group that was tre…”
MethodAntiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Askie, L. M., Duley, L., Henderson-Smart, D. J., & Stewart, L. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60712-0 · Cited by 1,020
Lisonkova, S., & Joseph, K. S. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.08.019 · Cited by 924
Souza, J. P., Gülmezoglu, A. M., Vogel, J., Carroli, G., Lumbiganon, P., Qureshi, Z., Costa, M. J., Fawole, B., Mugerwa, Y., Nafiou, I., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60686-8 · Cited by 757
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679
Self-citationO’Gorman, N., Wright, D., Syngelaki, A., Akolekar, R., Wright, A., Poon, L. C., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.034 · Cited by 629
Self-citationAspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
Roberge, S., Bujold, E., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.561 · Cited by 628
Self-citationCompeting Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers
Akolekar, R., Syngelaki, A., Poon, L., Wright, D., & Nicolaides, K. H. (2013) · Fetal Diagnosis and Therapy · doi:10.1159/000341264 · Cited by 601
Self-citationASPRE trial: performance of screening for preterm pre‐eclampsia
Rolnik, D. L., Wright, D., Poon, L. C. Y., Syngelaki, A., O'Gorman, N., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.18816 · Cited by 464
Self-citationAkolekar, R., Syngelaki, A., Sarquis, R., Zvanca, M., & Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2660 · Cited by 444
Self-citationUterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsia
Plasencia, W., Maiz, N., Bonino, S., Kaihura, C., & Nicolaides, K. H. (2007) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5157 · Cited by 425
Self-citationCompeting risks model in screening for preeclampsia by maternal characteristics and medical history
Wright, D., Syngelaki, A., Akolekar, R., Poon, L. C., & Nicolaides, K. H. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.02.018 · Cited by 417
Self-citationTurning the Pyramid of Prenatal Care
Nicolaides, K. H. (2011) · Fetal Diagnosis and Therapy · doi:10.1159/000324320 · Cited by 357
Self-citationWorld Health Organization Systematic Review of Screening Tests for Preeclampsia
Conde-Agudelo, A., Villar, J., & Lindheimer, M. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000147599.47713.5d · Cited by 326
Protocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' Gestation
Poon, L. C. Y., Zymeri, N. A., Zamprakou, A., Syngelaki, A., & Nicolaides, K. H. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000335366 · Cited by 260
Self-citationO'Gorman, N., Wright, D., Poon, L. C., Rolnik, D. L., Syngelaki, A., Wright, A., Akolekar, R., Cicero, S., Janga, D., Jani, J., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17399 · Cited by 259
Self-citationWorld Health Organization Systematic Review of Screening Tests for Preeclampsia
Cnossen, J. S., Mol, B. W., van Der Post, J. A. M., Bossuyt, P. M. M., & ter Riet, G. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000162539.68541.c2 · Cited by 249
A Competing Risks Model in Early Screening for Preeclampsia
Wright, D., Akolekar, R., Syngelaki, A., Poon, L. C. Y., & Nicolaides, K. H. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000338470 · Cited by 235
Self-citationA prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries
Saleem, S., McClure, E. M., Goudar, S. S., Patel, A., Esamai, F., Garces, A., Chomba, E., Althabe, F., Moore, J., Kodkany, B., et al. (2014) · Bulletin of the World Health Organization · doi:10.2471/blt.13.127464 · Cited by 191
Yu, C. K. H., Khouri, O., Onwudiwe, N., Spiliopoulos, Y., & Nicolaides, K. H. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5252 · Cited by 183
Self-citationTsiakkas, A., Duvdevani, N., Wright, A., Wright, D. E., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14811 · Cited by 173
Self-citationWright, D., Poon, L. C., Rolnik, D. L., Syngelaki, A., Delgado, J. L., Vojtassakova, D., de Alvarado, M., Kapeti, E., Rehal, A., Pazos, A., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.08.110 · Cited by 169
Self-citationTayyar, A., Guerra, L., Wright, A., Wright, D. E., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14789 · Cited by 128
Self-citationWright, A., Wright, D. E., Ispas, C. A., Poon, L. C., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14783 · Cited by 111
Self-citationManagement of Hypertensive Disorders During Pregnancy
Visintin, C., Mugglestone, M. A., Almerie, M. Q., Nherera, L. M., James, D., & Walkinshaw, S. (2011) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000400281.17500.1a · Cited by 24
Cited by
Poon, L. C., Shennan, A., Hyett, J. A., Kapur, A., Hadar, E., Divakar, H., McAuliffe, F., da Silva Costa, F., von Dadelszen, P., McIntyre, H. D., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12802 · Cited by 1,238
Self-citationMagee, L. A., Brown, M. A., Hall, D. R., Gupte, S., Hennessy, A., Karumanchi, S. A., Kenny, L. C., McCarthy, F., Myers, J., Poon, L. C., et al. (2022) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.09.008 · Cited by 1,134
Self-citationChappell, L. C., Cluver, C. A., Kingdom, J., & Tong, S. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32335-7 · Cited by 925
Dimitriadis, E., Rolnik, D. L., Zhou, W., Estrada-Gutierrez, G., Koga, K., Francisco, R. P. V., Whitehead, C., Hyett, J., da Silva Costa, F., Nicolaides, K., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00417-6 · Cited by 866
Self-citationScreening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation
Tan, M. Y., Syngelaki, A., Poon, L. C., Rolnik, D. L., O'Gorman, N., Delgado, J. L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., et al. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19112 · Cited by 438
Self-citation
Metadata
- Authors
- Tan, M. Y., Wright, D., Syngelaki, A., Akolekar, R., Cicero, S., Janga, D., Singh, M., Greco, E., Wright, A., Maclagan, K., Poon, L. C., & Nicolaides, K. H.
- Venue
- Ultrasound in Obstetrics & Gynecology
- Publisher
- Wiley
- Published
- 2018-03-14
- Volume
- 51
- Issue
- 6
- Pages
- 743-750
- ISSN
- 0960-7692 (ISSN-L)
- 1469-0705
- OpenAlex
- W2790948098
- Cited by
- 385
- References
- 32
- FWCI
- 33.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.